TREM2 (Triggering Receptor Expressed on Myeloid Cells 2), a receptor for PtdSer, has been found to play a significant role in AD pathogenesis in conjunction with microglia-mediated synaptic elimination. Here, TREM2 is linked to Alzheimer disease.